The target landscape of clinical kinase drugs.

The target landscape of clinical kinase drugs.

Item
http://www.wikidata.org/entity/Q47345032
Kinase-targeted cancer therapies: progress, challenges and future directions.New opportunities for kinase drug repurposing and target discovery.Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib.1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors.Prediction of Compound Profiling Matrices Using Machine Learning.New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitorsKInhibition: A Kinase Inhibitor Selection PortalComputationally derived compound profiling matricesA Conditional Dependency on MELK for the Proliferation of Triple-Negative Breast Cancer CellsDrug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profilesProbing the chemical-biological relationship space with the Drug Target ExplorerReconstructing phosphorylation signalling networks from quantitative phosphoproteomic data
P2860

The target landscape of clinical kinase drugs.

Item
http://www.wikidata.org/entity/Q47345032
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The target landscape of clinical kinase drugs.
@en
The target landscape of clinical kinase drugs.
@nl
type
label
The target landscape of clinical kinase drugs.
@en
The target landscape of clinical kinase drugs.
@nl
prefLabel
The target landscape of clinical kinase drugs.
@en
The target landscape of clinical kinase drugs.
@nl
P1433
P1476
P2093
P2860
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
The target landscape of clinical kinase drugs.
@en
P2093
P2860
P31
P356
P407
P433
P478
P50
P577
P698
P932